PSA and prostate cancer diagnosis.
作者信息
Savage P, Waxman J
出版信息
Eur J Cancer. 1996 Jun;32A(7):1097-9. doi: 10.1016/0959-8049(96)00098-6.
PMID:8758236
Abstract
摘要
相似文献
1
PSA and prostate cancer diagnosis.前列腺特异性抗原（PSA）与前列腺癌诊断
Eur J Cancer. 1996 Jun;32A(7):1097-9. doi: 10.1016/0959-8049(96)00098-6.
2
Prostatic specific antigen (PSA).前列腺特异性抗原（PSA）。
Minerva Urol Nefrol. 1993 Jun;45(2):83-4.
3
Inter-relation between measurement of serum prostatic specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer.
Br J Urol. 1992 Aug;70(2):183-7. doi: 10.1111/j.1464-410x.1992.tb15700.x.
4
Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.前列腺特异性抗原（PSA）检测用于前列腺癌筛查：当前的争议
Ann Oncol. 1998 Dec;9(12):1263-4. doi: 10.1023/a:1008435911379.
5
[Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].[使用前列腺特异性抗原（PSA）筛查前列腺癌：对一项系统评价和荟萃分析的评论]
Urologe A. 2019 Aug;58(8):925-928. doi: 10.1007/s00120-019-0990-6.
6
Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy.组织多肽特异性抗原：前列腺癌与良性前列腺增生之间的鉴别参数。
Eur J Cancer. 1993;29A(4):570-1. doi: 10.1016/s0959-8049(05)80153-4.
7
Prostate-specific antigen and other prostate cancer markers.前列腺特异性抗原及其他前列腺癌标志物。
Urology. 2000 Dec 20;56(6):893-8. doi: 10.1016/s0090-4295(00)00812-8.
8
9
[BIOMARKERS OF EARLY AND DIFFERENTIAL DIAGNOSIS OF PROSTATIC CANCER].[前列腺癌早期及鉴别诊断的生物标志物]
Klin Khir. 2017(1):54-7.
10
[Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate].[关于格龙德，A.，M. 奥斯特曼 - 迈劳：前列腺的良性和恶性疾病的评论]
Versicherungsmedizin. 1995 Apr 1;47(2):66-7.
Zotero 插件